When compared with participants without depression or subsequent cognitive decline, patients with LLD were shown to have elevated concentrations of CCL-2 and CCL-4 and cytokines IL-17a, IL-33, IFN-γ and IL-1ra, as well as IL-33 in most models. Here, CCL2 is linked to depressive symptom measurement.